This inhibition enhances the activity of tumor suppressor proteins, such as p53, inducing apoptosis and cell cycle arrest in various cancer cell lines, including cervical cancer, melanoma, and chronic lymphocytic leukemia [116]. The gene discussed is TP53; the disease is melanoma.